Concepedia

Author

Xiukun Hou

Tianjin Medical University Cancer Institute and Hospital

Also Known As

X Hou, X K Hou, Xiukun Hou

40

Publications

646

Citations

11

H-Index

36

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and HospitalTianjin Medical UniversityNankai UniversityTianjin First Center HospitalFujian Provincial Cancer Hospital
XH

About

Xiukun Hou is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

290

2

Cell Biology

4

4

275

3

Biomolecular Engineering

2

2

109

4

Engineering

1

1

15

5

Biochemistry

1

1

94

Xiukun Hou

×

11

Publications

573

Citations

11

H-Index

YearCitations

KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway

Wei Zhang, Xianhui Ruan, Yaoshuang Li,

Theranostics

2022

110

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma

Xiukun Hou, Xianle Shi, Wei Zhang,

Cell Death and Disease

2021

94

Antitumor effects of anlotinib in thyroid cancer

Xianhui Ruan, Xianle Shi, Qiman Dong,

Endocrine Related Cancer

2018

92

METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer

Junya Ning, Xiukun Hou, Jie Hao,

Cell Death and Differentiation

2023

74

Targeting Super-Enhancer-Driven Oncogenic Transcription by CDK7 Inhibition in Anaplastic Thyroid Carcinoma

Xinyi Cao, Lin Dang, Xiangqian Zheng,

Thyroid

2019

66

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway

Xiangrui Meng, Huijuan Wang, Jingzhu Zhao,

Frontiers in Oncology

2020

47

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib

Linfei Hu, Jun Zhang, Mengran Tian,

Cell Death and Disease

2022

24

NSUN2-mediated m<sup>5</sup>C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis

Xiukun Hou, Qiman Dong, Jie Hao,

Theranostics

2025

23

Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma

Jingtai Zhi, Yu Wu, Linfei Hu,

International Journal of Clinical Oncology

2019

15

A CRISPR-Cas9-Based Near-Infrared Upconversion-Activated DNA Methylation Editing System

Jiadong Chi, Jingzhu Zhao, Songfeng Wei,

ACS Applied Materials & Interfaces

2021

15

Page 1